Innate Pharma SA Equity
Innate Pharma SA (IPHYF) had Equity of -EUR 21.70 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:Equity · last filed 2026-04-01
- 2025-12-31: Equity -21.70M EUR.
- 2025-06-30: Equity 5.14M EUR.
- 2024-12-31: Equity 8.83M EUR.
- 2024-06-30: Equity 28.80M EUR.
| Period end | Equity | Equity as first filed |
|---|---|---|
| 2025-12-31 | -21.70M EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 5.14M EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | 8.83M EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 28.80M EUR 6-K · filed 2025-09-17 | |
| 2023-12-31 | 51.90M EUR 20-F · filed 2026-04-01 | |
| 2023-06-30 | 57.86M EUR 6-K · filed 2024-09-12 | |
| 2022-12-31 | 54.15M EUR 20-F · filed 2026-04-01 | |
| 2022-06-30 | 116.33M EUR 6-K · filed 2023-09-14 | |
| 2021-12-31 | 107.44M EUR 20-F · filed 2025-04-30 | |
| 2021-06-30 | 133.56M EUR 6-K · filed 2022-09-15 | |
| 2020-12-31 | 155.98M EUR 20-F · filed 2024-04-04 | |
| 2020-06-30 | 207.76M EUR 6-K · filed 2021-09-15 | |
| 2019-12-31 | 217.42M EUR 20-F · filed 2023-04-06 | |
| 2018-12-31 | 167.12M EUR 20-F · filed 2022-04-04 | 167.24M EUR 20-F · filed 2020-04-24 |
| 2017-12-31 | 99.44M EUR 20-F · filed 2021-04-27 | 85.96M EUR 20-F · filed 2020-04-24 |
| 2016-12-31 | 86.17M EUR 20-F · filed 2020-04-24 |